wsbdaily | Tue, 20 Dec 2022 03:11:25 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Emergent BioSolutions Inc.(EBS)
Emergent BioSolutions Inc.
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
United States
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox... Read More
Summary & Charts
| Price | $ 11.61 | -0.29 (-2.44%) |
| Day's Range | $ 11.52 - 12.04 | |
| Previous Close | $ 11.90 | |
| Market Cap | $ 579.2M USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NYSE | |
| Industry | Drug Manufacturers—Specialty & Generic | |
| Sector | Healthcare | |
| Volume | 882.32K | |
| Avg. Volume (20 day) | 998.42K | |
| Rel. Volume (20 day) | 0.88 | |
| Rel. Volume (3 month) | 1.17 | |
| Rating | B+ | Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 100.68 % | Buy |
| ROE | 3.48 % | Neutral |
| ROA | 2.45 % | Neutral |
| P/E | 6.87 % | Strong Sell |
| P/B | 0.40 % | Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | $ 11.80 | $ 12.04 | $ 11.52 | $ 11.61 | -0.29 | 882,323 | 0.88 | 1.17 | |
| Nov 25, 2022 | $ 11.68 | $ 12.17 | $ 11.62 | $ 11.90 | +0.07 | 373,313 | 0.38 | 0.50 | |
| Nov 23, 2022 | $ 11.91 | $ 12.09 | $ 11.58 | $ 11.83 | -0.22 | 665,942 | 0.67 | 0.90 | |
| Nov 22, 2022 | $ 11.95 | $ 12.34 | $ 11.72 | $ 12.05 | +0.21 | 845,010 | 0.84 | 1.15 | |
| Nov 21, 2022 | $ 12.23 | $ 12.25 | $ 11.80 | $ 11.84 | -0.48 | 678,264 | 0.67 | 0.93 | |
| Nov 18, 2022 | $ 12.45 | $ 12.54 | $ 11.77 | $ 12.32 | +0.21 | 967,899 | 0.97 | 1.32 | |
| Nov 17, 2022 | $ 12.10 | $ 12.39 | $ 11.89 | $ 12.11 | -0.08 | 925,934 | 0.94 | 1.27 | |
| Nov 16, 2022 | $ 13.10 | $ 13.32 | $ 12.15 | $ 12.19 | -1.12 | 1,184,604 | 1.23 | 1.63 | |
| Nov 15, 2022 | $ 13.75 | $ 14.34 | $ 13.19 | $ 13.31 | -0.14 | 1,158,309 | 1.23 | 1.60 | |
| Nov 14, 2022 | $ 15.50 | $ 15.68 | $ 13.42 | $ 13.45 | -2.29 | 1,088,900 | 1.20 | 1.49 | |
| Nov 11, 2022 | $ 14.43 | $ 15.95 | $ 14.39 | $ 15.74 | +0.74 | 1,130,230 | 1.27 | 1.56 | |
| Nov 10, 2022 | $ 13.49 | $ 15.39 | $ 13.27 | $ 15.00 | +2.15 | 2,458,559 | 2.87 | 3.43 | |
| Nov 09, 2022 | $ 17.39 | $ 17.39 | $ 12.00 | $ 12.85 | -6.88 | 3,885,231 | 5.15 | 5.60 | |
| Nov 08, 2022 | $ 20.33 | $ 20.51 | $ 19.48 | $ 19.73 | -0.57 | 611,157 | 1.04 | 0.94 | |
| Nov 07, 2022 | $ 20.13 | $ 20.54 | $ 19.89 | $ 20.30 | +0.34 | 506,614 | 0.86 | 0.78 | |
| Nov 04, 2022 | $ 19.88 | $ 20.33 | $ 19.38 | $ 19.96 | +0.43 | 625,361 | 1.05 | 0.96 | |
| Nov 03, 2022 | $ 19.62 | $ 19.92 | $ 19.16 | $ 19.53 | -0.55 | 390,537 | 0.65 | 0.60 | |
| Nov 02, 2022 | $ 20.70 | $ 21.22 | $ 20.06 | $ 20.08 | -0.84 | 591,447 | 0.97 | 0.90 | |
| Nov 01, 2022 | $ 21.25 | $ 21.56 | $ 20.85 | $ 20.92 | +0.06 | 433,730 | 0.72 | 0.66 | |
| Oct 31, 2022 | $ 21.15 | $ 21.45 | $ 20.82 | $ 20.86 | -0.59 | 565,024 | 0.89 | 0.86 |
News
The latest news about Emergent BioSolutions Inc. (EBS).
Zacks Investment Research | 2022-11-09 12:02:10
Emergent's (EBS) third-quarter 2022 earnings and revenues miss estimates. EBS issues fresh guidance for its CDMO services
Seeking Alpha | 2022-11-08 21:47:09
Emergent BioSolutions Inc. (NYSE:EBS ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Bob Burrows - Vice President, Investor Relations Bob Kramer - President & Chief Executive Officer Rich Lindahl - Chief Financial Officer Conference Call Participants Jessica Fye - JPMorgan Keay Nakae - Chardan Brandon Folkes - Cantor Operator Good day and thank you for standing. Welcome to the Emergent BioSolutions Third Quarter 2022 Earnings Conference Call.
Zacks Investment Research | 2022-11-08 21:04:10
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -2,016.67% and 10.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
InvestorPlace | 2022-10-24 14:05:47
These top small-cap stocks to buy present daring investors with significant upside. Fundamentally, companies with a relatively diminutive profile typically command higher growth potential.
GlobeNewsWire | 2022-10-18 06:30:00
GAITHERSBURG, Md., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, November 8, 2022, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2022, recent business developments, and financial outlook for full year 2022.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2023-01-09 | AMC | 0.04 | -- | -- | 297M | -- | -- |
| 2022-11-08 | AMC | -0.06 | -1.27 | 2016.66% | -- | -- | -- |
| 2022-08-01 | AMC | 0.38 | -0.86 | -326.32% | -- | -- | -- |
| 2022-04-28 | AMC | 0.13 | 0.18 | 38.46% | 284M | 308M | 8.33% |
| 2022-02-24 | AMC | 4.27 | 4.50 | 5.38% | 0.6B | 0.7B | 15.03% |
| 2022-01-09 | AMC | -- | -- | -- | 0.6B | 0.7B | 15.03% |
| 2021-11-04 | AMC | 2.03 | -0.36 | -117.74% | 487M | 329M | -32.43% |
| 2021-07-29 | AMC | 1.81 | 0.33 | -81.77% | 398M | 398M | -- |
Top Discussions
These are the top discussions over the last 24-hours that mention the EBS stock ticker symbol.
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Mon, 13 Dec 2021 12:00 EST
@wsbdaily
wsbdaily